Saira Farid, MD
Hematology & Oncology · Jackson, TNNPI 1659876894
Payments from drug & device makers
Across 34 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$84
- Daiichi Sankyo Inc.$83
- Merck$57
- E.r. Squibb & Sons, L.L.C.$52
- Novartis$50
- Lilly USA, LLC$47
- plus $379 from 17 others
What the payments were for
- Food & beverage$752100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $84 |
| Daiichi Sankyo Inc. | 3 | $83 |
| Merck | 2 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Novartis | 2 | $50 |
| Lilly USA, LLC | 2 | $47 |
| AstraZeneca | 2 | $41 |
| AVEO Pharmaceuticals, Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $26 |
| Genentech USA, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $22 |
| Exelixis Inc. | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Caris MPI, Inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| GSK | 1 | $20 |
| Bristol Myers Squibb | 1 | $19 |
| Sanofi | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $17 |
| Array Biopharma Inc | 1 | $17 |
How this compares
$752 in reported general payments places this provider in the 10th percentile of 251 hematology & oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Jackson
- Erika HamiltonNashville$45.4M
- Ian FlinnNashville$41.2M
- Johanna BendellNashville$28.5M
- Jesus BerdejaNashville$22.2M
- Meredith McKeanNashville$16M
- Krish PatelNashville$14.2M
- Kathryn BeckermannFranklin$13.6M
- Denise YardleyNashville$13.2M
- Todd BauerNashville$10.9M
- Bertrand AnzChattanooga$9.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.